Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-186686
Filing Date
2006-09-07
Accepted
2006-09-07 13:45:01
Documents
6
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 797023
2 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1961
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 2247
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8866
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8872
6 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 3959
  Complete submission text file 0001193125-06-186686.txt   824292
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 061078806
SIC: 2835 In Vitro & In Vivo Diagnostic Substances